|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Alfred EngelbergPublisher: Post Hill Press Imprint: Post Hill Press Dimensions: Width: 14.00cm , Height: 1.30cm , Length: 21.00cm Weight: 0.184kg ISBN: 9798888456729Pages: 176 Publication Date: 28 January 2025 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationAlfred Engelberg is widely regarded as the legal father of the modern generic drug industry for his work on the Hatch-Waxman Act, which created the framework for the explosive growth in generic drug use. Engelberg was a pioneer in challenging improperly granted drug patents that block generic competition on important medicines. He is the author of numerous articles on regulation of brand and generic competition, high prices on new drugs, the role of patent monopolies on drug price competition and innovation, drug shortages, and more. Al has degrees in Chemical Engineering (Drexel, 1961) and law (New York University, 1965) and has worked as a patent examiner, a patent agent for Exxon, a Justice Department trial lawyer, and a partner in an intellectual property law practice. He founded NYU’s Engelberg Center on Innovation Law and Policy, is a fellow of the New York Academy of Medicine, and has been honored by NYU and others for his achievements in law and philanthropy. Tab Content 6Author Website:Countries AvailableAll regions |